The possibility that contraceptives are more likely to fail in obese patients is only one reason why you need to take a different tack when counseling them about their most appropriate birth control options. . .
. . . You need to advise them, too, that combination oral contraceptives (COCs) may put overweight or obese women at increased risk for both arterial and venous thromboembolic disease-as may certain other birth control methods. These concerns, combined with the ever-growing obesity epidemic among reproductive-aged American women, make it imperative for us to focus family planning efforts on our overweight patients.
Obese women are at higher risk of unintended pregnancy than their non-obese counterparts. Data from a study of more than 24,000 women, which examined the intendedness of pregnancy, contraceptive use, body weight, and BMI at the time of conception, suggested that overweight and obese women using contraception were more likely than non-obese women to unintentionally get pregnant.2 This difference wasn't seen in women who weren't using birth control at the time they conceived. These findings suggest that the overall effectiveness of contraceptives is decreased in overweight and obese women.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More